Skip to content

Antihypertensives in Non-cardiac Surgical Population

Current Status of Antihypertensive Drug Treatment in Non-cardiac Surgical Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03953872
Enrollment
351
Registered
2019-05-17
Start date
2018-11-23
Completion date
2019-04-01
Last updated
2019-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Antihypertensive

Brief summary

A cohort of hypertension patients undergoing elective non-cardiac surgery was constructed to investigate current status of antihypertensive drug treatment in non-cardiac surgical population.

Detailed description

Perioperative changes in blood pressure (BP) are associated with perioperative risks. However, there is little information regarding the current status of antihypertensive treatment in non-cardiac surgical population. A cohort of 351 hypertension patients aged between 18 to 85-year old undergoing elective non-cardiac surgery was constructed to investigate the application of antihypertensive drugs, systemic involvement, perioperative hemodynamics and internal environment to grasp the perioperative impact of different antihypertensive drugs, and to further provide a reference for the preoperative antihypertensive strategy of surgery patients.

Interventions

None listed

Sponsors

RenJi Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing elective non-cardiac surgery with hypertension(i.e., with a systolic blood pressure(SBP) of \>=140 mmHg and/or a diastolic blood pressure(DBP) of \>=90 mmHg based on the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) or self-reported use of antihypertensive medication

Exclusion criteria

* Patients under the age of 18 years old * Patients more than 85 years old * Patients suspected of intracranial hypertension

Design outcomes

Primary

MeasureTime frameDescription
perioperative blood press(BP)from the moment on arrival to the operating room until the moment leaving PACU, assessed up to 240 minutes.baseline BP before the operation, when entering and exiting post-anesthesia care unit(PACU)

Secondary

MeasureTime frameDescription
pH, base excess, and concentration of HCO3- in blood gases5 minutes after extubating in PACUarterial blood gases detected by using the ABL800 (Radiometer Med Aps Ltd, Copenhagen, Denmark)
the incidence of hypotension in PACUfrom the moment on arrival to PACU until 60 minutes after arriving or the moment leaving PACU, whichever came first, assessed up to 240 minutes.If there were more than two consecutive episodes of hypotension (which was defined as SBP less than 80% of baseline) a rescue intravenous bolus of 100 mg of phenylephrine was given.
the incidence of hypertension in PACUfrom the moment on arrival to PACU until 60 minutes after arriving or the moment leaving PACU, whichever came first, assessed up to 240 minutes.the incidence of hypertension, which was defined as SBP greater than 120% of baseline
hospitalization daysfrom the date of admission until the date of discharge or date of death from any cause, whichever came first, assessed up to 100 daysThe duration of this single episode of hospitalization

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026